Could you give us a brief description of your start-up and explain the reasons that led you to establish it up?
OaCP produces and sells innovative reagents able to reduce the time and costs of DNA diagnostic tests, for cancer patients.
OaCP was born from the desire of the team partners to provide all laboratories with the best possible technology for cancer diagnosis, making advanced tests not only faster but also more accessible for patients.
Your reagents could reduce diagnosis time and cost. What is your target as regards commercial development?
We currently do not have commercial limits. Our intent is to reach the main European diagnostic institutes (for which we already have the appropriate certifications) and then expand our business in both USA and the Asian markets.
For this reason, we are looking for investors, who can support us financially, and for commercial partners.